285 related articles for article (PubMed ID: 29079545)
1. THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1.
Lin F; Zhang D; Chang J; Tang X; Guan W; Jiang G; Zhu C; Bian F
Eur J Med Genet; 2018 Feb; 61(2):84-88. PubMed ID: 29079545
[TBL] [Abstract][Full Text] [Related]
2. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
[TBL] [Abstract][Full Text] [Related]
3. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
4. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
[TBL] [Abstract][Full Text] [Related]
5. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
[TBL] [Abstract][Full Text] [Related]
10. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G
Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
[TBL] [Abstract][Full Text] [Related]
12. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.
Iwakura T; Ohashi N; Kato A; Baba S; Yasuda H
PLoS One; 2015; 10(9):e0138841. PubMed ID: 26393352
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
[TBL] [Abstract][Full Text] [Related]
15. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
[TBL] [Abstract][Full Text] [Related]
16. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy.
Wanderley DC; Jones BD; Barbosa FAM; Araujo SA
J Bras Nefrol; 2019 Oct; 42(2):254-258. PubMed ID: 31663595
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
18. Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients.
Wang G; Sun L; Dong H; Wang Y; Xu X; Zhao Z; Cheng W; Liu X; Zhao X; Geng Y; Bao S; Chen Y; Cheng H
Clin J Am Soc Nephrol; 2021 May; 16(5):727-735. PubMed ID: 33849930
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features in membranous nephropathy with cancer: A retrospective single-center study and literature review.
Zhang D; Zhang C; Bian F; Zhang W; Jiang G; Zou J
Int J Biol Markers; 2019 Dec; 34(4):406-413. PubMed ID: 31617780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]